Phase III study of gemcitabine plus docetaxel versus capecitabine plus docetaxel for anthracycline-pretreated metastatic breast cancer patients: survival results

被引：0

作者：

Chan, S.

Romieu, G.

Huober, J.

Tubiana-Hulin, M.

Schneeweiss, A.

Lluch, A.

Llombart, A.

du Bois, A.

Carrasco, E.

Thareau, Vaury A.

Fumoleau, P.

机构：

[1] City Hosp Nottingham, Nottingham, England

[2] CRLC Val Aurelle, Montpellier, France

[3] Univ Tubingen, Tubingen, Germany

[4] Ctr Rene Huguenin, St Cloud, France

[5] Univ Heidelberg, Heidelberg, Germany

[6] Hosp Clin Valencia, Valencia, Spain

[7] Hosp Arnau Villanova, Lerida, Spain

[8] Eli Lilly & Co, Suresnes, France

[9] Ctr Georges Francois Leclerc, Dijon, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S68 / S68

页数：1